|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
3
|
Resverlogix Corp.
|
Dec 02, 2019 10:50AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 12:10PM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
2
|
Resverlogix Corp.
|
Dec 02, 2019 12:12PM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
2
|
Resverlogix Corp.
|
Dec 02, 2019 01:00PM
|
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 09:02AM
|
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 10:08AM
|
|
Re: Resverlogix H2 2018 events
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 12:56PM
|
|
Re: Resverlogix H2 2018 events
|
1
|
Resverlogix Corp.
|
Sep 29, 2018 11:37AM
|
|
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
|
2
|
Resverlogix Corp.
|
Jan 13, 2020 08:40AM
|
|
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
|
3
|
Resverlogix Corp.
|
Jan 13, 2020 09:57AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 27, 2020 11:51AM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
1
|
Resverlogix Corp.
|
Apr 01, 2019 08:58AM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
2
|
Resverlogix Corp.
|
Apr 01, 2019 09:25AM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
2
|
Resverlogix Corp.
|
Apr 01, 2019 10:48AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 07:36AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
2
|
Resverlogix Corp.
|
Jul 15, 2019 06:53PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 30, 2020 12:10PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
|
Resverlogix Corp.
|
Mar 30, 2020 09:20AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
7
|
Resverlogix Corp.
|
Mar 30, 2020 09:32AM
|
|
Re: RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS April 17, 2018
|
1
|
Resverlogix Corp.
|
May 14, 2019 08:49PM
|
